NHS priorities

Whether it’s to prepare for the next Pharmacy Quality Scheme deadline, or to increase your confidence in helping people with a learning disability, this section provides topic-specific pages that link to current NHS priorities. This section will support you in keeping your knowledge and skills up to date in order to provide high-quality pharmacy services and be service-ready.

Clinical pharmacy

Our clinical portfolio is expanding on a frequent basis, helping you to advance your knowledge and skills and deliver medicines optimisation in practice for all sectors of pharmacy. From two new focal points a year to our small group learning for hospital pharmacists – Optimise – this section focuses on clinical pharmacy, diseases and therapeutics.

Public health

The public health agenda is embedded in pharmacy, yet topics such as emergency contraception or stop smoking support are as prevalent as ever. As well as our public health workshops, use this section to access a wide range of resources to assure and maintain your competence, all underpinned by the Declaration of Competence system.

Anticoagulation

FalseplayTrue

Transcript

There are approximately 1.25 million people living in the UK, that are on long-term anticoagulation therapy to treat conditions such as deep vein thrombosis and pulmonary embolism. The need for anticoagulation is expected to increase in coming years as the UK population ages and the rates of atrial fibrillation (AF) rise. Anticoagulants are one of the classes of medicines most frequently identified as having a greater potential to cause serious patient harm if prescribed, dispensed or administered incorrectly. As we are seeing a greater number of patients on anticoagulants and in particular on the new oral anticoagulants, we as pharmacists and pharmacy technicians have a vital role in supporting our patients by providing appropriate information to patients and their carers to help them manage their therapy more effectively. Use our learning programmes to develop your knowledge and skills to support patients adhere to their anticoagulant therapy, to work within the best practice guidance and improve the safe use of anticoagulants.

Falsequestion-signTrue
FalselaptopTrue

Anticoagulants are one of the classes of medicines most frequently identified as having a greater potential to cause serious patient harm if prescribed, dispensed or administered incorrectly. This e-learning programme is designed to equip learners with the knowledge to deliver a safe and supportive service to patients prescribed anticoagulants including the newer oral anticoagulants.

Please note: this e-learning programme has been developed and provided by the Northern Ireland Centre for Pharmacy Learning and Development (NICPLD). Users should recognise that this programme will refer to Northern Ireland's policies and organisations. After ordering this programme, you will be redirected to their website where the resource is hosted. Please be aware that CPPE does not maintain control over the accuracy and currency of this programme.


6h:00m (for events this includes pre and post event learning)


Learning Outcomes:

On completion of all aspects of this learning programme you should be able to:

  • state the indications for anticoagulant therapy
  • describe the mode of action of the oral and parenteral anticoagulants that are currently available
  • advise on the importance of regular INR monitoring for coumarin anticoagulants
  • identify and resolve common medicines management issues for anticoagulated patients
  • follow best practice guidance to improve safe use of anticoagulants
  • promote safe use of anticoagulants for pregnant women
  • provide appropriate information to patients and their carers to help them manage their therapy more effectively.
FalseglobeTrue

The aim of this e-course is to develop your knowledge and skills in cardiovascular therapeutics. This will enable you to provide a person-centred approach to support the healthcare of people living with or at higher risk of cardiovascular disease. It is designed for pharmacy professionals working in all areas of practice.

To facilitate your learning, we have structured the course into seven units. Some units are larger than others, but we estimate that you will need to commit an average of three hours of learning for each unit.

  • Unit 1 – Introduction to cardiovascular therapeutics
  • Unit 2 – Atrial fibrillation
  • Unit 3 – Blood pressure
  • Unit 4 – Cholesterol
  • Unit 5 – Stable angina
  • Unit 6 – Acute coronary syndrome
  • Unit 7 – Heart failure


21h:00m (for events this includes pre and post event learning)


Learning Outcomes:

On completion of all aspects of this learning programme, you should be able to:

  • describe the anatomy and function of the cardiovascular system
  • explain the changes to cardiovascular system anatomy and function occurring in common cardiovascular conditions
  • identify opportunities to develop your role and professional networks to deliver holistic and seamless care for people living with or at higher risk of cardiovascular disease
  • apply your knowledge of medicines and cardiovascular guidelines to support evidence-based decisions and medicines optimisation for the prevention and treatment of cardiovascular disease
  • demonstrate a shared decision making approach to the care of people living with or at higher risk of cardiovascular disease
  • create a personal action plan that describes the actions you will take to support people living with or at higher risk of cardiovascular disease
FalselaptopTrue

The aim of this piece of learning is to support you to become more confident with biochemistry results and managing medicines in relation to those results. We have a series of case studies on different topics to help put your learning into practice.

This case study forms part of the Biochemistry learning gateway. On this learning gateway page, you will find a range of learning resources which aim to increase your knowledge, skills, and confidence in relation to biochemistry.


1h:00m (for events this includes pre and post event learning)


Learning Outcomes:

On completion of all aspects of this learning programme you should be able to:

  • list the relevant blood results you would review when you identify a person at risk of Deep Vein Thrombosis (DVT)
  • recognise how pharmacy professionals can support people to make choices about different types of anticoagulation treatment.
FalsepairedTrue

This factsheet aims to refresh your knowledge of pulmonary embolism (PE) and provide you with links to appropriate further resources. It covers the definitions and risk factors for PE and deep vein thrombosis (DVT), the prevalence and incidence of PE and DVT; as well as causes, complications and management of PE and DVT.

FalsecheckTrue

This e-assessment is linked with the CPPE Fundamentals of cardiovascular therapeutics e-course programme, and assesses you on the learning outcomes in that programme. 


Why should I do this assessment?

This e-assessment completes the learning you began with the CPPE Fundamentals of cardiovascular therapeutics e-course. Access and successful completion will contribute to your own personal development plan, be recorded in your My CPPE record and will enable you to complete a CPD entry on the learning. It may also provide evidence for achieving competencies in the RPS Foundation or Advanced Pharmacy Frameworks. If you are working towards completing a Declaration of Competence for a pharmacy service, successful completion of this assessment will provide evidence of your learning.

Falsenew-windowTrue
external resource

Written by expert consultants and clinical scientists currently practising in the UK, the BSH Guidelines provide up-to-date evidence-based guidance on the diagnosis and treatment of haematological diseases.

Falsenew-windowTrue
external resource

This guideline covers diagnosing and managing atrial fibrillation in adults. It includes guidance on providing the best care and treatment for people with atrial fibrillation, including assessing and managing risks of stroke and bleeding.

FalsepairedTrue

You may find the following article useful to learn more about the use of the CHA2DS2-VASC tool.

Falsenew-windowTrue
external resource

Calculate the stroke risk for patients with atrial fibrillation using the CHADSVASC app (apple users only)

FalsepairedTrue

Predicts bleeding risk in patients on anticoagulation for afib.

Please help us improve our website by letting us know what you like and reporting anything that isn't quite right.